SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action.
作者信息
Packer Milton
机构信息
Baylor Scott & White Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX
Imperial College, London, U.K.
出版信息
Diabetes Care. 2020 Mar;43(3):508-511. doi: 10.2337/dci19-0074.
PMID:32079684
Abstract
摘要
Zotero 插件